Merck & Co. Short-term debt and current portion of long-term debt decreased by 5.6% to $2.44B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 79.7%, from $1.36B to $2.44B. Over 5 years (FY 2020 to FY 2025), Short-term debt and current portion of long-term debt shows a downward trend with a -16.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Lower levels reduce immediate liquidity pressure, while high levels may signal a need for refinancing or significant cash outflows.
The portion of total debt obligations, including bank loans and notes, that is due for repayment within the next twelve...
A key indicator of short-term financial health compared to peers with similar capital structures.
other_debt_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.49B | $3.53B | $2.41B | $1.21B | $2.98B | $1.94B | $1.95B | $2.67B | $2.84B | $887.00M | $1.37B | $3.08B | $3.07B | $3.15B | $2.65B | $1.36B | $1.43B | $1.41B | $2.59B | $2.44B |
| QoQ Change | — | +42.0% | -31.7% | -49.9% | +146.6% | -35.0% | +0.5% | +37.3% | +6.3% | -68.8% | +54.7% | +124.3% | -0.2% | +2.5% | -15.9% | -48.7% | +5.4% | -2.0% | +84.3% | -5.6% |
| YoY Change | — | — | — | — | +19.7% | -45.2% | -19.3% | +121.2% | -4.7% | -54.2% | -29.5% | +15.2% | +8.2% | +255.0% | +93.1% | -55.8% | -53.3% | -55.4% | -2.3% | +79.7% |